Barcelona min

Join Bruker's Drug Development and QC Evening in Barcelona

Martes 29 Octubre, 2019

Bruker Events

La Pharma Night de Bruker llega a Barcelona y le brinda a la comunidad farmacéutica española, la oportunidad de interactuar y compartir conocimientos e ideas sobre las soluciones analíticas en Resonancia Magnética Nuclear. Nos complace organizar este evento tan especial y esperamos un día muy animado.

From 5:30pm - 9:30pm

Programa

Encuentro y Reunión de medio día, de 17:30 a 21:30 el martes 29 de Octubre en Barcelona
El programa completo se notificarà más adelante.

Barcelona, ES

Dónde y Cuándo

Martes 29 de Octubre en Barcelona, desde las 17:30 a 21:30  h

Pullman Barcelona Skipper
Av. del Litoral, 10,
08005 Barcelona,
España

Pharma Night in Barcelona

05.30pm Registration & coffee
05.45pm Welcome & Introduction Dr. Eric Leonardis (Regional Sales Manager, Western & Southern Europe)
06.00pm Innovative solutions for the Pharmaceutical Industry Dr. Anna Codina (Director, Pharmaceutical Business Unit)
06.15pm Using NMR under GMP and GLP: How Bruker BioSpin Can Help Achieve Compliance Dr. Sukhvinder Chohan (BDM Europe)
06.30pm qNMR Certification and Qualification Dr. Markus Obkircher (Head of Reference Materials R&D, Merck KGaA Darmstadt)
06.55pm 19FNMR for characterization and screening of a library of fluorinated fragments Dr Juan Felix Espinosa (Eli Lilly Spain)
07.20pm Novel Solutions for the Quantification and Characterisation of Polymorphs and Amorphous Form Dr. Anna Codina (Director, Pharmaceutical Business Unit)
07.35pm Drug safety, impurity profiling, shelf life Dr. Sukhvinder Chohan (BDM Europe)
07.50pm Simple mixture analysis applied to pharmaceuticals Dr. Irakusne Lopez (Scientific End User Relationship Manager, Mestrelab Research)
08.05pm Q&A
08.15pm Finger food & networking till 9.30pm

Bruker's Pharma World Tour 2019
Barcelona, ES

Are you a Bruker customer?: *
Where does your department belong to::

 

Dear Sir/Madam,

Thank you for registering for the Bruker Pharma event.

Your registration was forwarded successfully.

With best regards, 


Your Bruker BioSpin Team